Abstract
Planning and managing pregnancy in the context of an existing rheumatic disease is a serious problem widely discussed in the medical community. Behcet’s syndrome (Behcet’s disease) is one of the least studied diseases in this context. Data on the mutual influence of vasculitis and pregnancy on the course and outcomes are contradictory. There is an obvious need for interdisciplinary support of pregnancy by an obstetrician-gynecologist and a rheumatologist to minimize the risk of losses and complications in this complex clinical situation. This review presents data published over the past two decades on the use of genetically engineered biological drugs in rheumatology.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
